Voxar strengthens presence in U.S. and Japan

Article

Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.Voxar recently announced an agreement with Japanese distributor Kanagawa to

Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.

Voxar recently announced an agreement with Japanese distributor Kanagawa to handle its medical 3-D imaging software, Plug ’n View, which can be used on standard PC hardware. Voxar said it expects to generate around $3 million in revenue in Japan over the next three years.

Andrew Bissell, its CEO, founded the company in 1995 in Edinburgh. Voxar has about 40 employees with offices in the U.S., Asia Pacific, and Europe, and hopes to double that staff in the near future.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.